Quantcast

Latest Lactams Stories

2014-07-14 08:26:29

Submission based on first head-to-head study vs. oral treatments in real world context TITUSVILLE, N.J., July 14, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking a label change that, if approved, would include new data showing significantly delayed time to relapse in patients prescribed once-monthly atypical long-acting antipsychotic INVEGA(®)...

2014-07-11 08:24:35

Agreement with Biotie ends option for purchase and allows Neurelis to advance development of NRL-1 in preparation for NDA filing SAN DIEGO, July 11, 2014 /PRNewswire/ -- Neurelis, Inc. ("Neurelis") today announced an agreement with Biotie Therapies Corp. ("Biotie") to end the option held by Biotie to purchase Neurelis, clearing the way for Neurelis to commence further development of NRL-1 (intranasal diazepam) for pediatric and adult epilepsy patients who experience acute repetitive...

2014-07-10 08:27:07

LUGANO, Switzerland, July 10, 2014 /PRNewswire/ -- Helsinn Group, the company focused on building quality cancer care, today announces that the complete results of the three Phase 2/3 pivotal trials for the investigational oral fixed-dose combination capsule of netupitant 300 mg + oral palonosetron 0.50 mg (NEPA), which is licensed to Eisai Inc. in the United States, have been published, together with an accompanying editorial, in the July issue of Annals of Oncology....

2014-07-08 23:08:08

Matters Involving Ongoing Litigation to Be Discussed DALLAS (PRWEB) July 08, 2014 Parties involved in lawsuits regarding the anti-psychotic drug Risperdal are scheduled to meet in the Philadelphia Court of Common Pleas to hold a conference to discuss moving litigation forward, the national law firm of Baron and Budd reports. The plaintiffs in the lawsuits accuse Janssen Pharmaceuticals, as well as parent company Johnson & Johnson, of allegedly failing to properly warn users of...

2014-07-08 23:00:27

The DrugNews Center is the largest source for prescription drug and medical device warnings, research and legal news. Visit http://www.DrugNews.net today. New York, NY (PRWEB) July 08, 2014 The prescription drug safety center DrugNews.net has added new research information to the site for patients who have taken popular erectile dysfunction drugs like Viagra. A recent European study shows a high percentage of erectile dysfunction drug use is not prescribed*. This follows another recent...

2014-07-07 23:00:59

Launch of the Risperdal Lawsuits for Gynecomastia Page Comes as Hundreds of Plaintiffs Seek Compensation for Gynecomastia, a Condition Marked by the Excessive Growth of Male Breast Tissue, Which is Allegedly Caused by Risperdal. Chicago IL (PRWEB) July 07, 2014 The Oliver Law Group P.C. a harmful drug law firm, announces that they have launched a Risperdal lawsuit for Gynecomastia page in response to the growing Risperdal gynecomastia litigation underway in Pennsylvania state court. Court...

2014-07-03 23:01:07

The Firm is representing a number of Risperdal lawsuit clients in the Pennsylvania litigation who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic drug. New York, New York (PRWEB) July 03, 2014 Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) that allege the atypical antipsychotic medication caused gynecomastia (male breast growth) in men and boys continue to move forward in a mass tort proceeding underway in Pennsylvania’s...

2014-07-03 11:43:01

BMJ-British Medical Journal Consumption of illicit drugs might dwarf the consumption of legitimate versions At least two-thirds of the erectile dysfunction drug sildenafil (e.g. Viagra) consumed in the Netherlands may be illegal, warn researchers today. In a letter published on bmj.com, they say the consumption of illicit drugs might dwarf consumption of legitimate versions – and they call for the further inquiry into the apparent success of rogue online pharmacies. It follows...

2014-06-27 23:01:53

The Firm is representing a number of men and boys in Risperdal lawsuits that claim use of the atypical antipsychotic medication caused gynecomastia (male breast growth). New York, New York (PRWEB) June 27, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that a newly released study has linked Risperdal to low bone mass in children. The study, which was presented earlier this month at the American...

2014-06-27 08:26:41

DUBLIN, June 27, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/2m9962/caprolactam) has announced the addition of the "2014 Report on the International Caprolactam (Textiles, Carpets, Industrial Yarns, Engineering Plastics, Packaging, Electronics) Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The demand for caprolactam is mainly prompted by growing demand from engineering applications and...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'